MCRB - Seres Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue28,26732,10021,766-
Cost of Revenue95,95589,45581,98938,095
Gross Profit-67,688-57,355-60,223-38,095
Operating Expenses
Research Development----
Selling General and Administrative32,59634,04032,61616,761
Non Recurring----
Others----
Total Operating Expenses128,551123,495114,60554,856
Operating Income or Loss-100,284-91,395-92,839-54,856
Income from Continuing Operations
Total Other Income/Expenses Net1,3422,0151,26076
Earnings Before Interest and Taxes-100,284-91,395-92,839-54,856
Interest Expense----
Income Before Tax-98,942-89,380-91,579-54,780
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-98,942-89,380-91,579-54,780
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-98,942-89,380-91,579-54,780
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-98,942-89,380-91,579-54,780